Source: Medical Product Outsourcing

Micro Interventional Devices: Micro Interventional Devices and Neovasc Settle TMVR Lawsuit

Neovasc will pay MID $3M upfront over 2 years, and a 1.3 percent royalty on commercial sales of its Tiara device.

Read full article »
Micro Interventional Devices's Competitors | Micro Interventional Devices's News | Micro Interventional Devices's Financials
Stay up-to-date with the latest news on MID
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Michael P. Whitman's photo - President & CEO of MID

President & CEO

Michael P. Whitman

CEO Approval Rating

91/100

Read more
Stay up-to-date with the latest news on MID